Diagnostic performance of copeptin in patients with acute nontraumatic chest pain: BWH-TIMI ED chest pain study

Clinical Cardiology

Volumn 37, Issue 4, 2014, Pages 227-232

  Sukul, Devraj ^a   Bonaca, Marc P ^a   Ruff, Christian T ^a   Kosowsky, Joshua ^b   Conrad, Michael ^a   Murphy, Sabina A ^a   Sabatine, Marc S ^a   Jarolim, Petr ^a   Morrow, David A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPEPTIN; TROPONIN I; BIOLOGICAL MARKER; GLYCOPEPTIDE;

ACUTE NONTRAUMATIC CHEST PAIN; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; EMERGENCY WARD; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NONCARDIAC CHEST PAIN; RECEIVER OPERATING CHARACTERISTIC; TASK PERFORMANCE; THORAX PAIN; ACUTE DISEASE; BLOOD; CHEST PAIN; EMERGENCY HEALTH SERVICE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; UNITED STATES;

ACUTE DISEASE; AGED; BIOLOGICAL MARKERS; CHEST PAIN; EMERGENCY SERVICE, HOSPITAL; FEMALE; GLYCOPEPTIDES; HUMANS; MASSACHUSETTS; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; TROPONIN I;

EID: 84899051753     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22244     Document Type: Article

References (27)

1. Bhuiya FA, Pitts SR, McCaig LF,. Emergency department visits for chest pain and abdominal pain: United States, 1999-2008. NCHS Data Brief 2010;(43): 1-8.
2. Antman EM, Hand M, Armstrong PW, et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 writing group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction, writing on behalf of the 2004 writing committee. J Am Coll Cardiol. 2008; 51: 210-247.
3. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol. 2007; 50: e1-157.
4. Morrow DA, Antman EM,. Evaluation of high-sensitivity assays for cardiac troponin. Clin Chem. 2009; 55: 5-8.
5. Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction. Eur Heart J. 2007; 28: 2525-2538.
6. Libby P, Theroux P,. Pathophysiology of coronary artery disease. Circulation. 2005; 111: 3481-3488.
7. Robertson GL,. Antidiuretic hormone. Normal and disordered function. Endocrinol Metab Clin North Am. 2001; 30: 671-694, vii.
8. Krismer AC, Dunser MW, Lindner KH, et al. Vasopressin during cardiopulmonary resuscitation and different shock states: a review of the literature. Am J Cardiovasc Drugs. 2006; 6: 51-68.
9. Mutlu GM, Factor P,. Role of vasopressin in the management of septic shock. Intensive Care Med. 2004; 30: 1276-1291.
10. Katan M, Morgenthaler N, Widmer I, et al. Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stress level. Neuro Endocrinol Lett. 2008; 29: 341-346.
11. Morgenthaler NG, Struck J, Alonso C, et al. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem. 2006; 52: 112-119.
12. Reichlin T, Hochholzer W, Stelzig C, et al. Incremental value of copeptin for rapid rule out of acute myocardial infarction. J Am Coll Cardiol. 2009; 54: 60-68.
13. Keller T, Tzikas S, Zeller T, et al. Copeptin improves early diagnosis of acute myocardial infarction. J Am Coll Cardiol. 2010; 55: 2096-2106.
14. Karakas M, Januzzi JL Jr, Meyer J, et al. Copeptin does not add diagnostic information to high-sensitivity troponin T in low- to intermediate-risk patients with acute chest pain: results from the rule out myocardial infarction by computed tomography (ROMICAT) study. Clin Chem. 2011; 57: 1137-1145.
15. Eggers KM, Venge P, Lindahl B,. High-sensitive cardiac troponin T outperforms novel diagnostic biomarkers in patients with acute chest pain. Clin Chim Acta. 2012; 413: 1135-1140.
16. Meune C, Zuily S, Wahbi K, et al. Combination of copeptin and high-sensitivity cardiac troponin T assay in unstable angina and non-ST-segment elevation myocardial infarction: a pilot study. Arch Cardiovasc Dis. 2011; 104: 4-10.
17. Morrow DA, Rifai N, Tanasijevic MJ, et al. Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a Thrombolysis In Myocardial Infarction (TIMI) 11B Substudy. Clin Chem. 2000; 46: 453-460.
18. Melanson SE, Morrow DA, Jarolim P,. Earlier detection of myocardial injury in a preliminary evaluation using a new troponin I assay with improved sensitivity. Am J Clin Pathol. 2007; 128: 282-286.
19. DeLong ER, DeLong DM, Clarke-Pearson DL,. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988; 44: 837-845.
20. Maisel A, Mueller C, Neath SX, et al. Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction). J Am Coll Cardiol. 2013; 62: 150-160.
21. Liebetrau C, Nef H, Szardien S, et al. Release kinetics of copeptin in patients undergoing transcoronary ablation of septal hypertrophy. Clin Chem. 2013; 59: 566-569.
22. McGinn AP, Rosamond WD, Goff DC Jr, et al. Trends in prehospital delay time and use of emergency medical services for acute myocardial infarction: experience in 4 US communities from 1987-2000. Am Heart J. 2005; 150: 392-400.
23. Body R, Carley S, McDowell G, et al. Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay. J Am Coll Cardiol. 2011; 58: 1332-1339.
24. Chatterjee S, Kim J, Dahhan A, et al. Use of high-sensitivity troponin assays predicts mortality in patients with normal conventional troponin assays on admission-insights from a meta-analysis. Clin Cardiol. 2013; 36: 649-653.
25. Kolditz M, Halank M, Schulte-Hubbert B, et al. Copeptin predicts clinical deterioration and persistent instability in community-acquired pneumonia. Respir Med. 2012; 106: 1320-1328.
26. Potocki M, Breidthardt T, Mueller A, et al. Copeptin and risk stratification in patients with acute dyspnea. Crit Care. 2010; 14: R213.
27. Neuhold S, Huelsmann M, Strunk G, et al. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease. J Am Coll Cardiol. 2008; 52: 266-272.